Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Detroit, MI

96 studies for Lung Cancer are recruiting at 399 sites within 50 miles of Detroit, Michigan, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Detroit.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Detroit

Showing the 50 nearest of 96 studies.
  1. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Henry Ford Hospital (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    45 sites within 50 mi
  2. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Henry Ford Hospital (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    36 sites within 50 mi
  3. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Henry Ford Hospital (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    32 sites within 50 mi
  4. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Hospital (Detroit, MI); Wayne State University/Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    28 sites within 50 mi
  5. Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

    NCT03191149

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Henry Ford Hospital (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    27 sites within 50 mi
  6. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    NCT04181060

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Corewell Health Dearborn Hospital (Dearborn, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    23 sites within 50 mi
  7. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    NCT06498635

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Henry Ford Hospital (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    23 sites within 50 mi
  8. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Hospital (Detroit, MI); Henry Ford Medical Center-Fairlane (Dearborn, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    16 sites within 50 mi
  9. Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

    NCT06769126

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Henry Ford Saint John Hospital - Academic (Grosse Pointe Woods, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    15 sites within 50 mi
  10. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Henry Ford Hospital (Detroit, MI); Henry Ford Medical Center - Detroit Northwest (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  11. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    NCT06767514

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Clinical Study Site (Detroit, MI); Clinical Study Sites (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  12. Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

    NCT06881784

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Health (Detroit, MI); Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  13. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Exelixis Clinical Site #13 (Detroit, MI); Exelixis Clinical Site #65 (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

    NCT05208762

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Karmanos Cancer Institute (Detroit, MI); Karmanos Cancer Institute (Farmington Hills, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    NCT06253871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Cancer Institute (Detroit, MI); University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

    NCT06500481

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Wayne State University/Karmanos Cancer Institute (Detroit, MI); Weisberg Cancer Treatment Center (Farmington Hills, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

    NCT04198766

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

    NCT04614103

    • Phase 2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

    NCT05490472

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Health System (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

    NCT05579366

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

    NCT05592626

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

    NCT05669430

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Study of DB-1310 in Advanced/Metastatic Solid Tumors

    NCT05785741

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Health System (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

    NCT05797168

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: All

    Nearest site: Research Site (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

    NCT05856981

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

    NCT05903092

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Center (Wayne State University) (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    NCT05914116

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site 129 (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    NCT06026410

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Health System (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

    NCT06162221

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

    NCT06179069

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Barbara Ann Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

    NCT06228326

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Health (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

    NCT06244771

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

    NCT06293898

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institiute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

    NCT06343402

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Cancer - Detroit (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

    NCT06350097

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy

    NCT06439914

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Study of DM005 in Patients With Advanced Solid Tumors

    NCT06515990

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06586515

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Barbara Ann Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

    NCT06692738

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

    NCT06706076

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Health (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

    NCT06772623

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Hospital - Detroit /ID# 271642 (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

    NCT06799065

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

    NCT06855771

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

    NCT06868485

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

    NCT06875310

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

    NCT06922539

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

    NCT07070232

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Brigitte Harris Cancer Pavilion BHCP (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

    NCT07111520

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Health System (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

    NCT07155174

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Hospital - Detroit /ID# 277218 (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.